We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of GNCA yet.

GNCA Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2024, worth a combined $0 — down 100% from $1 a quarter earlier.

Fund positioning in GNCA was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Genocea Biosciences, Inc. (GNCA) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $0 of Genocea Biosciences, Inc. stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Genocea Biosciences, Inc. positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.